BrainStorm Announces Positive Top Line Results from the U.S. Phase 2 Study of NurOwn in Patients with Amyotrophic Lateral Sclerosis ALS

Press/Media: Press / Media

PeriodAug 3 2016

Media coverage

1

Media coverage

  • TitleBrainStorm Announces Positive Top Line Results from the U.S. Phase 2 Study of NurOwn in Patients with Amyotrophic Lateral Sclerosis ALS
    Media name/outletPharmacy Choice
    CountryUnited States
    Date8/3/16
    PersonsCarlayne E Jackson